Astrazeneca Company News



Company:
Epic Code:
ISIN No:
StockName:
Group:
Sector:
Sub Sector:
Country:
Region:
Market:
Market Cap:

ASTRAZENECA PLC
AZN
GB0009895292
ORD USD0.25
4577
Pharmaceuticals & Biotechnology
Pharmaceuticals
UK
London
UK Main Market
41446.4387748 GBPm


Data as of 10:00 23/09/2009. Check director details and other company announcments at Astrazeneca Website .



RNS News for Astrazeneca





Regulatory News Service : RNS provides a service that enables local or international listed companies to meet company news reporting obligations in UK, Europe and US - international filings use different processes: Provides investors & professionals equal access to new company information as it is released. For further details of RNS news see London Stock Exchange website.



Latest Astrazeneca News



AstraZeneca escapes lawsuit over clinical drug trial
Reuters - 11 hours ago
A federal judge has dismissed claims against AstraZeneca PLC by a Massachusetts lawyer who claimed he was misled into participating in a clinical trial of a cholesterol drug that failed to treat his kidney disease.

06/26/2017 10:00 PM


Market Risers: Associated British Foods plc, AstraZeneca plc, Aviva plc ...
DirectorsTalk Interviews - 20 hours ago
The stock price for AstraZeneca plc found using EPIC: LON:AZN has risen 1.26% or 68 points throughout today's trading session so far.

06/26/2017 01:22 PM


Form 6-K ASTRAZENECA PLC For: Jun 23
StreetInsider.com - Jun 23, 2017
AstraZeneca today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending the marketing authorisation of Faslodex (fulvestrant) for the treatment ...
AstraZeneca Gets Recommendation For Breast Cancer Treatment Faslodex - London South East (registration) (blog)

06/23/2017 12:48 PM


GlaxoSmithKline and AstraZeneca among drug stocks buoyed by Trump's healthcare ...
Proactive Investors UK - Jun 23, 2017
Analysts have also suggested that the uptick in the sector could also be down to investors moving away from technology stocks and looking to invest elsewhere.

06/23/2017 07:56 AM


For AstraZeneca, Cancer Drug Weighs on Go-It-Alone Stand -- WSJ
Fox Business - Jun 20, 2017
LONDON - AstraZeneca PLC Chief Executive Pascal Soriot made a promise to investors three years ago as the Anglo-Swedish drug maker was fending off takeover advances from Pfizer Inc.: If left alone, AstraZeneca would nearly double its revenue within a ...

06/20/2017 07:56 AM


Can AstraZeneca Thrive on Its Own? Big Test Looms
Wall Street Journal (subscription) - Jun 19, 2017
LONDON—AstraZeneca PLC Chief Executive Pascal Soriot made a promise to investors three years ago as the Anglo-Swedish drug maker was fending off takeover advances from Pfizer Inc.: If left alone, AstraZeneca would nearly double its revenue within a ...

06/19/2017 01:00 PM